TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR IN HUMAN RENAL CELL CARCINOMA

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1979 • 22,482 citations

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

1984 • 3,268 citations

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1991 • 2,774 citations

Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade

1986 • 764 citations

Antibodies to plasminogen activator inhibit human tumor metastasis

1983 • 651 citations

Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).

1988 • 484 citations

Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.

1986 • 443 citations

Plasminogen activator inhibitors: hormonally regulated serpins

1990 • 409 citations

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

1993 • 396 citations

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1993 • 367 citations

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

1987 • 295 citations

Structure of two human beta-actin-related processed genes one of which is located next to a simple repetitive sequence.

1983 • 176 citations

Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma

1994 • 169 citations

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma.

1991 • 147 citations

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.

1990 • 131 citations

Plasminogen activator inhibitor‐1 is induced in migrating endothelial cells

1992 • 115 citations

Type‐1 plasminogen activator inhibitor in human breast carcinomas

1992 • 100 citations

Differential protease expression by cutaneous squamous and basal cell carcinomas.

1991 • 95 citations

REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 mRNA IN HUMAN ENDOTHELIAL CELLS

1987 • 87 citations

Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.

1993 • 67 citations

Regulation of Plasminogen Activator Inhibitor-1 mRNA in Human Endothelial Cells

1988 • 65 citations

Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin)

1992 • 62 citations

Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney

1996 • 55 citations

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

1992 • 54 citations

The role of the urokinase receptor in extracellular matrix degradation by ht29 human colon carcinoma cells

1993 • 49 citations

Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.

1992 • 43 citations

Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

1995 • 34 citations

Clinical implications of pathologic subtypes in renal cell carcinoma.

1990 • 32 citations

Expression of Stromelysin 3 in the Stromal Elements of Human Basal Cell Carcinoma

1992 • 30 citations

Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectin

1993 • 28 citations

Increased urokinase activity to antigen ratio in human renal‐cell carcinoma

1985 • 19 citations

Prognostic factors in renal cell carcinoma.

1986 • 9 citations

Plasminogen activator inhibitor type 1 and 2 in human breast cancer

1992 • 7 citations